Patrick Merel, Ph.D.
Founder and CEO
Dr. Merel, an expert in molecular diagnostics and an early developer of robotics for the automation of molecular diagnostics from forensics to transplantations, is the founder of Portable Genomics’ technology.
Previously, he was with Beckman Coulter, Inc., where he helped start the Nucleic Acid Business Center in San Diego. Dr. Merel has built an extensive background in business development and intelligence, and has worked with major IVD (In Vitro Diagnostics) players in Asia, Europe and the U.S. While at the University of Bordeaux, Dr. Merel was involved in the Biomedical Innovation Platform where he developed the concept of a wireless genomics platform designed to bring genomic data to professionals and consumers. Mr. Merel serves as a Member of the Advisory Board at Edico Genome Inc. He received a Ph.D. in Molecular Biology from Bordeaux University.
Board of Directors
Emile Loria, MD
Chairman of the Board
Emile Loria is chairman and co-founder of OSE Pharma. He has more than 25 years of experience in the pharmaceutical and biotechnology sectors, occupying key positions, in particular with Ciba-Geigy and Sanofi Pharma.
He was a researcher in the cancer institute in Villejuif and then in the cancer and immunogenetics institute (INSERM-CNRS) founded by professor Georges Mathe. In 1986, he founded MS Medical Synergy, a company that specializes in drug management, after which he joined Biovector Therapeutics and became chairman and CEO.
Francois Ferre, Ph.D.
Dr. Ferre is co-chairman and co-founder of Althea Dx and a co-founder of Althea Technologies, Inc. He has over 20 years of experience in cancer research and HIV clinical development. Dr. Ferre has held management positions at Cytometics and The Immune Response Corporation.
He is a leader in gene quantification and biomarker development with over 15 years of experience in the field. He received his Ph.D. in Molecular Oncology from the Pasteur Institute in Lille, France and did his post-doctoral training at the University of California-San Diego.
Magda Marquet, Ph.D.
Dr. Marquet has over 25 years of experience in the biotechnology industry in both the United States and Europe. She is the founder and co-CEO of ALMA LifeSciences LLC, an investment and consulting firm. She is also the co-chairman and co-founder of Ajinomoto Althea. She was co-President and CEO of Althea Technologies for ten years prior to the company’s acquisition by Ajinomoto.
Dr. Marquet is also co-founder and Director of Althea Dx, a spin-off of Althea Technologies focusing in personalized medicine, companion diagnostics development and pharmacogenomics. Prior to starting Althea, she held management positions at Vical Inc., Amylin Pharmaceuticals, Protein Polymer Technologies, Syntro Corporation and Transgene. Dr. Marquet is an active angel investor, having provided early stage funding and advice for over 20 San Diego companies. Dr. Marquet holds a Ph.D. in Biochemical Engineering from INSA/University of Toulouse, France.
Mr. Millon is the retired former President and Chief Executive Officer of PCS Health Systems, Inc. (“PCS”). Mr. Millon joined PCS in 1995, where he served as President and Chief Executive Officer from June 1996 until his retirement in September 2000.
Mr. Millon previously served on the board of Caremark Rx, Inc. from March 2004, upon Caremark’s acquisition of AdvancePCS, and as a director of AdvancePCS (which resulted from the merger of PCS and Advance Paradigm, Inc.) beginning in October 2000. He became a director of CVS Health upon the March 2007 closing of the merger of Caremark and CVS Health. Mr. Millon has ten years of financial management experience and fifteen years of general functional management experience, including strategic planning experience specific to pharmacy benefit management companies as the former head of PCS. He also has extensive venture capital and public and private company board experience, and presently serves on the CEO advisory board of a private equity fund.
Mr. Fremont was President and Chief Operating Officer of Solar Gard in San Diego, an independent division of Bekaert that he sold to Saint-Gobain in 2011. He oversaw globally all aspects of the company’s strategic vision, business, sales initiatives and financial operations.
Fremont brought the company from a U.S. centric company status to a company recognized globally as a strong player in the energy saving industry, selling products in more than 90 countries, with 6 plants all over the world and more than 15 offices internationally. He has full knowledge of mergers and acquisition process and sold a mid-size company at high-level EBITDA multiple.
Mr. Vigouroux is an entrepreneur and a former top athlete. In 1991, at the young age of 26, Vigouroux created Pro-System, a service company specializing in the management of refrigerated display cabinet fleets. Fifteen years later, Pro-System Group organized into three subsidiaries with an employment of 200 people and developed internationally while continuing to strengthen its leading position.
Mr. Vigouroux’s athletic career took place from 1995 to 2014. He led a race team in the rally-raid discipline where he was a professional driver and team manager. He participated in 15 editions of the Dakar Rally and numerous FIA World Cup events. In 2012, he became World Champion in his class and he won the international Rally of Morocco a few months later. Mr. Vigouroux is currently working on a project to build an all-terrain 100% electric vehicle.
Aarush Manchanda, MD
Dr. Aarush Manchanda is in the trenches of heart disease and precision medicine every day—and has been for over 10 years. After graduating from fellowship in 2010 and being board certified in five specialties: internal medicine, cardiovascular disease, nuclear cardiology, cardiac computed tomography, and echocardiography, he took the role of Medical Director of Cardiovascular Services at Intermountain Cedar City Hospital in Utah. He currently works as a cardiology faculty at Baystate Medical Center in Springfield MA, affiliated with University of Massachusetts.
In this role, he brought comprehensive cardiology services including state of the art multimodality cardiology, once thought to be only a fantasy for the rural community of Cedar City, into the realm of everyday practice.
Dr. Aarush Manchanda has made it his life’s work to facilitate a health-conscious community and is at the forefront of shared decision making and personalized medicine.
He strongly believes this to be the mantra for “precision cardiology”, a term coined by him. His first step towards precision cardiology is educating people about the heart and how it works, and continuously seeks ways to make understanding complex health issues accessible to everyone.
To develop individualized plans for healthy lifestyle changes he has been working with a New York start-up Fruitstreet where he serves as an advisor.
Dr. Aarush Manchanda lives with his wife, daughter and son in Longmeadow, Massachusetts and spends his leisure time skiing, playing golf, and meditating.
Raffi Krikorian is currently engineering lead at Uber’s Advanced Technologies Group. He previously served as vice-president of engineering at Twitter and also served at the famed MIT Media Lab. Krikorian serves as an adviser of Granatus Ventures.
He co-founded Ennovationz Inc. in 2008 and is a member of the Board of Advisors. He also serves as a board advisor to Corporacion America. He received a Bachelor’s degree and two Master’s degrees from MIT.
Larry Smarr is the founding Director of the California Institute for Telecommunications and Information Technology (Calit2), a UC San Diego/UC Irvine partnership, and holds the Harry E. Gruber professorship in Computer Science and Engineering (CSE) at UCSD’s Jacobs School.
At Calit2, Smarr has continued to drive major developments in information infrastructure — including the Internet, Web, scientific visualization, virtual reality, and global telepresence — begun during his previous 15 years as founding Director of the National Center for Supercomputing Applications (NCSA). Smarr served as principal investigator on NSF’s OptIPuter project and currently is principal investigator of the Moore Foundation’s CAMERA project and co-principal investigator on NSF’s GreenLight project. In October 2008 he was the Leadership Dialog Scholar in Australia.
Yannis Viniotis, Ph.D.
Dr. Viniotis’ current research interests are in the areas of service engineering, design of high-speed networks (with special emphasis on quality of service, transport protocols, ASIC implementations) and network algorithm analysis. In 1992 and 1993, Dr. Viniotis chaired two international conferences on networking.
In 1995, he was a guest editor for the Performance Evaluation Journal’s special issue on high-speed networks. In 1997, he authored a textbook on probability theory and random processes. In 1998, Dr. Viniotis co-founded Orologic, a successful startup company in RTP; Vitesse Semiconductor Corporation acquired Orologic in March 2000. While at Orologic, Dr. Viniotis designed two chips for Quality of Service in IP and ATM networks, the first such chips that operate at 2.4 Gbps. In 2004, he authored a textbook on mathematical principles for electrical and computer engineers. He received his Ph.D. in Electrical Engineering from the University of Maryland, College Park.